Alonso Javier, Frayle Helena, Menéndez Ibis, López Andrés, García-Miguel Purificación, Abelairas José, Sarret Enric, Vendrell M Teresa, Navajas Aurora, Artigas Mercé, Indiano José M, Carbone Ana, Torrenteras Christian, Palacios Itziar, Pestaña Angel
Oncogenetic Laboratory (OncoLab), Instituto de Investigaciones Biomédicas Alberto Sols, CSIC-UAM, 28029 Madrid, Spain.
Hum Mutat. 2005 Jan;25(1):99. doi: 10.1002/humu.9299.
Constitutional mutations in the RB1 gene predispose to retinoblastoma development. Hence genetic screening of retinoblastoma patients and relatives is important for genetic counseling purposes. In addition, RB1 gene mutation studies may help decipher the molecular mechanisms leading to tumors with different degrees of penetrance or expressivity. In the course of genetically screening of 107 hereditary and non-hereditary retinoblastoma patients (11 familiar bilateral, 4 familiar unilateral, 49 sporadic bilateral and 43 sporadic unilateral) and kindred from Spain, Colombia and Cuba, using direct PCR sequencing, we observed 45 distinct mutations and four RB1 deletions in 53 patients (9 familiar bilateral, 2 familiar unilateral, 31 sporadic bilateral and 11 sporadic unilateral). Most of these mutations (26/45, 57%) have not been reported before. In 32 patients, the predisposing mutations correspond to nonsense (mainly CpG transitions) and small insertions or deletions whose expected outcome is a truncated Rb protein that lacks the functional pockets and tail. Five single aminoacid replacements and seventeen mutations affecting splicing sites were also observed in retinoblastoma patients. Two of these sixteen mutations are of unclear pathogenic nature.
RB1基因的体质性突变易引发视网膜母细胞瘤。因此,对视网膜母细胞瘤患者及其亲属进行基因筛查对于遗传咨询至关重要。此外,RB1基因突变研究可能有助于阐明导致具有不同程度外显率或表达性的肿瘤的分子机制。在对来自西班牙、哥伦比亚和古巴的107例遗传性和非遗传性视网膜母细胞瘤患者(11例家族性双侧、4例家族性单侧、49例散发性双侧和43例散发性单侧)及其亲属进行基因筛查的过程中,我们采用直接PCR测序法,在53例患者(9例家族性双侧、2例家族性单侧、31例散发性双侧和11例散发性单侧)中观察到45种不同的突变和4例RB1基因缺失。这些突变中的大多数(26/45,57%)此前未曾报道过。在32例患者中,易患性突变对应于无义突变(主要是CpG转换)以及小的插入或缺失,其预期结果是产生一种截短的Rb蛋白,该蛋白缺乏功能性结构域和尾部。在视网膜母细胞瘤患者中还观察到5个单氨基酸替换和17个影响剪接位点的突变。这16个突变中有2个的致病性质尚不清楚。